Latest filing published 01 Mar 2023 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €9,561.
This profile gathers the share dealings of Seana Lynne Carson in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Between 10 May 2022 and 28 February 2023, the trades on record add up to 6 filings.
On the market, this insider has only sold: 1 sale, €1,889 in total. Other entries cover 2 option exercises. In 2023 alone, the filings show no purchases and 1 sale.
On 1 March 2023 came the latest disclosure, an option exercise for €9,561 in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Filings reach the SEDI feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations